S-Palmitoylation of a Novel Site in the β2-Adrenergic Receptor Associated with a Novel Intracellular Itinerary

被引:39
|
作者
Adachi, Naoko [1 ,2 ,3 ,5 ]
Hess, Douglas T. [1 ,2 ,3 ]
McLaughlin, Precious [1 ,2 ,3 ]
Stamler, Jonathan S. [1 ,2 ,3 ,4 ]
机构
[1] Case Western Reserve Univ, Sch Med, Inst Transformat Mol Med, Cleveland, OH 44106 USA
[2] Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA
[3] Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA
[4] Univ Hosp Case Med Ctr, Harrington Discovery Inst, Cleveland, OH 44106 USA
[5] Kobe Univ, Biosignal Res Ctr, Kobe, Hyogo 6578501, Japan
基金
美国国家卫生研究院;
关键词
adrenergic receptor; G protein-coupled receptor (GPCR); membrane trafficking; protein palmitoylation; receptor desensitization; ACYL-PROTEIN THIOESTERASE; BETA-2-ADRENERGIC RECEPTOR; PHOSPHORYLATION SITES; AGONIST STIMULATION; MOLECULAR-CLONING; MEMBRANE DOMAINS; ALPHA-SUBUNITS; NITROSYLATION; ACTIVATION; PALMITATE;
D O I
10.1074/jbc.M116.725762
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We report here that a population of human (2)-adrenergic receptors ((2)AR), a canonical G protein-coupled receptor, traffics along a previously undescribed intracellular itinerary via the Golgi complex that is associated with the sequential S-palmitoylation and depalmitoylation of a previously undescribed site of modification, Cys-265 within the third intracellular loop. Basal S-palmitoylation of Cys-265 is negligible, but agonist-induced (2)AR activation results in enhanced S-palmitoylation, which requires phosphorylation by the cAMP-dependent protein kinase of Ser-261/Ser-262. Agonist-induced turnover of palmitate occurs predominantly on Cys-265. Cys-265 S-palmitoylation is mediated by the Golgi-resident palmitoyl transferases zDHHC9/14/18 and is followed by depalmitoylation by the plasma membrane-localized acyl-protein thioesterase APT1. Inhibition of depalmitoylation reveals that S-palmitoylation of Cys-265 may stabilize the receptor at the plasma membrane. In addition, (2)AR S-palmitoylated at Cys-265 are selectively preserved under a sustained adrenergic stimulation, which results in the down-regulation and degradation of AR. Cys-265 is not conserved in (1)AR, and S-palmitoylation of Cys-265 may thus be associated with functional differences between (2)AR and (1)AR, including relative resistance of (2)AR to down-regulation in multiple pathophysiologies. Trafficking via the Golgi complex may underlie new roles in G protein-coupled receptor biology.
引用
收藏
页码:20232 / 20246
页数:15
相关论文
共 50 条
  • [31] β1 and β2-adrenergic receptor gene polymorphisms are not associated with heart failure
    Lavandero, S
    Moraga, F
    Mellado, R
    Chiong, M
    Diaz-Araya, G
    Castro, P
    Greig, D
    Perez, O
    Moreno, M
    FASEB JOURNAL, 2003, 17 (04): : A652 - A652
  • [32] β2-Adrenergic Receptor Gene Polymorphism Is Associated with Mortality in Septic Shock
    Nakada, Taka-aki
    Russell, James A.
    Boyd, John H.
    Aguirre-Hernandez, Rosalia
    Thain, Katherine R.
    Thair, Simone A.
    Nakada, Emiri
    McConechy, Melissa
    Walley, Keith R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181 (02) : 143 - 149
  • [33] Investigation of allosteric coupling in human β2-adrenergic receptor in the presence of intracellular loop 3
    Ozgur, Canan
    Doruker, Pemra
    Akten, E. Demet
    BMC STRUCTURAL BIOLOGY, 2016, 16
  • [34] Beta 2-adrenergic receptor agonists are novel regulators of macrophage activation in diabetic renal and cardiovascular complications
    Noh, Hyunjin
    Yu, Mi Ra
    Kim, Hyun Joo
    Lee, Ji Hye
    Park, Byoung-Won
    Wu, I-Hsien
    Matsumoto, Motonobu
    King, George L.
    KIDNEY INTERNATIONAL, 2017, 92 (01) : 101 - 113
  • [35] Signaling pathways mediated by the β2-adrenergic receptor in the fibroblast:: A novel role for Pl 3-kinase
    Vlahos, CJ
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2001, 33 (06) : 1049 - 1051
  • [36] Effect of C-Terminal S-Palmitoylation on D2 Dopamine Receptor Trafficking and Stability
    Ebersole, Brittany
    Petko, Jessica
    Woll, Matthew
    Murakami, Shoko
    Sokolina, Kate
    Wong, Victoria
    Stagljar, Igor
    Luescher, Bernhard
    Levenson, Robert
    PLOS ONE, 2015, 10 (11):
  • [37] Agonistic Autoantibodies to the α1-Adrenergic Receptor and the β2-Adrenergic Receptor in Alzheimer's and Vascular Dementia
    Karczewski, P.
    Hempel, P.
    Kunze, R.
    Bimmler, M.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2012, 75 (05) : 524 - 530
  • [38] α2-Adrenergic Blockade as a Novel Drug Therapy for Obstructive Sleep Apnea
    Song, Gang
    Poon, Chi-Sang
    FASEB JOURNAL, 2017, 31
  • [39] A NOVEL α2 AGONIST PHOTOLABEL REVEALS A BINDING SITE FOR DEXMEDETOMIDINE ON THE α2A ADRENERGIC RECEPTOR
    McKinstry-Wu, Andrew
    Woll, Kellie
    White, E. Railey
    Bhanu, Natarajan
    Garcia, Benjamin
    Dailey, William
    Eckenhoff, Roderic G.
    ANESTHESIA AND ANALGESIA, 2018, 126 (04): : 60 - 61
  • [40] Probing the Existence of a Metastable Binding Site at the β2-Adrenergic Receptor with Homobivalent Bitopic Ligands
    Gaiser, Birgit I.
    Danielsen, Mia
    Marcher-Rorsted, Emil
    Jorgensen, Kira Ropke
    Wrobel, Tomasz M.
    Frykman, Mikael
    Johansson, Henrik
    Brauner-Osborne, Hans
    Gloriam, David E.
    Mathiesen, Jesper Mosolff
    Pedersen, Daniel Sejer
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (17) : 7806 - 7839